Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BAQ13-NP
- Development stage
- Unknown
- Lead developer
- University of California, Davis
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
BAQ13-NP is a novel nanoparticle-encapsulated bisaminoquinoline derivative designed for the treatment of glioblastoma (GBM). Developed by researchers at UC Davis, it aims to overcome the limitations of traditional aminoquinolines, such as hydroxychloroquine, by enhancing potency and blood-brain barrier (BBB) penetration. The mechanism of action involves the inhibition of autophagy, evidenced by the accumulation of LC3B and p62, and the suppression of IL-6-dependent STAT3 phosphorylation in tumor cells and the immune microenvironment. Preclinical studies in orthotopic murine glioma models (GL261 and CT2A) demonstrated significant survival improvements and reduced tumor growth following systemic administration. BAQ13-NP has received Investigational New Drug (IND) approval and is transitioning into Phase I clinical trials.
- Other names
- bisaminoquinoline derivative nanoparticle
02
Targets
NeuraminidaseIL-6 (Interleukin 6)STAT3 (Signal Transducer and Activator of Transcription 3)
Beyond the preview
Go deeper on BAQ13-NP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BAQ13-NP.